UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
TriMas Corp
TRS
$1.43B
| $1.23M | ﹤0.01% |
48,916
| – | – |
|
1802
Valaris
VAL
$5.94B
| $1.22M | ﹤0.01% |
25,017
-1,021
| -4% | -$48.9K |
|
1803
Triumph Financial Inc
TFIN
$1.8B
| $1.22M | ﹤0.01% |
22,457
+507
| +2% | +$33.4K |
|
1804
Vir Biotechnology
VIR
$1.5B
| $1.22M | ﹤0.01% |
63,231
-15,335
| -20% | -$390K |
|
1805
Newmark Group
NMRK
$2.52B
| $1.22M | ﹤0.01% |
150,881
-50,904
| -25% | -$525K |
|
1806
Seaboard Corp
SEB
$4.06B
| $1.21M | ﹤0.01% |
357
| – | – |
|
|
DVAX
1807
DELISTED
Dynavax Technologies
DVAX
| $1.21M | ﹤0.01% |
116,352
-1,204
| -1% | -$15.7K |
|
1808
Core & Main
CNM
$8.67B
| $1.21M | ﹤0.01% |
53,318
-20,568
| -28% | -$481K |
|
|
TBI
1809
Trueblue
TBI
$323M
| $1.21M | ﹤0.01% |
63,323
+3,831
| +6% | +$77.5K |
|
1810
Fiverr
FVRR
$327M
| $1.2M | ﹤0.01% |
39,336
+5,907
| +18% | +$210K |
|
|
MODN
1811
DELISTED
MODEL N, INC.
MODN
| $1.2M | ﹤0.01% |
35,137
+275
| +0.8% | +$7.95K |
|
|
FLNA
1812
Filana Therapeutics
FLNA
$48.2M
| $1.2M | ﹤0.01% |
28,748
-3,778
| -12% | -$102K |
|
1813
Nabors Industries
NBR
$1.33B
| $1.2M | ﹤0.01% |
11,850
-1,014
| -8% | -$124K |
|
1814
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.2M | ﹤0.01% |
43,684
| – | – |
|
|
COWN
1815
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.2M | ﹤0.01% |
31,083
-910
| -3% | -$33.1K |
|
1816
First Busey Corp
BUSE
$2.55B
| $1.2M | ﹤0.01% |
54,618
+2,088
| +4% | +$49.5K |
|
1817
Grid Dynamics Holdings
GDYN
$621M
| $1.2M | ﹤0.01% |
64,071
-2,952
| -4% | -$56K |
|
1818
LiveRamp
RAMP
$2.3B
| $1.2M | ﹤0.01% |
66,034
-13,785
| -17% | -$319K |
|
1819
Enova International
ENVA
$6.29B
| $1.19M | ﹤0.01% |
40,750
-5,818
| -12% | -$195K |
|
1820
Zillow
ZG
$7.66B
| $1.19M | ﹤0.01% |
41,570
-7,668
| -16% | -$267K |
|
|
EHAB
1821
DELISTED
Enhabit
EHAB
| $1.18M | ﹤0.01% |
+84,360
| New | +$1.37M |
|
1822
Matthews International
MATW
$717M
| $1.18M | ﹤0.01% |
52,823
| – | – |
|
1823
Medifast
MED
$135M
| $1.18M | ﹤0.01% |
10,845
-1,960
| -15% | -$281K |
|
1824
MGP Ingredients
MGPI
$381M
| $1.17M | ﹤0.01% |
11,031
+574
| +5% | +$61.7K |
|
|
IMGN
1825
DELISTED
Immunogen Inc
IMGN
| $1.17M | ﹤0.01% |
244,602
+24,834
| +11% | +$131K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.